299. 嚢胞性線維症 Cystic fibrosis Clinical trials / Disease details
臨床試験数 : 1,695 / 薬物数 : 1,527 - (DrugBank : 268) / 標的遺伝子数 : 111 - 標的パスウェイ数 : 174
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01155752 (ClinicalTrials.gov) | July 2013 | 25/6/2010 | Pulmozyme in Cystic Fibrosis With Sinusitis | Z4770s, Use of Recombinant Human DNASE in Cystic Fibrosis Patients With Chronic Sinusitis to Prevent Acute Sinusitis Exacerbations and Improve Symptoms and Outcomes - A Pilot Study | Sinusitis;Cystic Fibrosis | Drug: Pulmozyme single use ampule;Drug: placebo | Milton S. Hershey Medical Center | Genentech, Inc. | Withdrawn | 12 Years | 65 Years | All | 0 | Phase 3 | United States |